Interview with Jitirto Kusnadi, President, Mersifarma
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Address: Wisma Tiara 4th Floor Jl. Raya Pasar Minggu Km. 18 No. 17 Jakarta Indonesia
Tel: +62 21 7987683
Web: http://www.mersifarma.com/
PT Mersifarma TM, better known as “Mersi’, was established in 1997. The company initially focused on the manufacturing of medicines to combat Neuro-Psychiatric, Psychosomatic and Mental Health Diseases. Today other important areas of healthcare in which Mersi is involved are Internal Medicine, Pulmonary Diseases, Obstetrics-Gynaecology, Neuro-surgery, Ear-Nose and Throat Diseases, Dentistry, and advanced antibiotic therapeutic agents.
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Wiwy Sasongko, MD at QuintilesIMS Indonesia, describes his efforts to continuously improve the services provided to his clients and explains the revolution that the universal healthcare coverage program in Indonesia…
Omar Luqmaan Harris, GM at GSK Indonesia, discusses the commitment of the Indonesian affiliate to the global organization’s mission, as well as their focus on being the best place to…
Dr. Kuntjoro Adi Purjanto, Chairman of PERSI (National Association of Hospitals in Indonesia), explains the role that public and private hospitals are playing to successfully realize the national healthcare goals…
Herny Prasetya, President of the International Society of Pharmaceutical Engineering (ISPE) in Indonesia highlights the importance of the implementation of global guidelines in Indonesia and wishes to focus on human…
Dede Yusuf is advocating for more people in Indonesia to take up a healthy lifestyle and, through his position of Chairman of Commission IX of the House of Representatives, is…
Mada Shinta Dewi, country manager at Mundipharma Indonesia, explains the unique business model of Mundipharma in Indonesia, collaboration with the local business community, and the benefits that the company’s consumer…
Ashish D. Pal, President Director at MSD Indonesia, discusses the importance of introducing innovative pharmaceuticals, vaccines and biologics to address significant unmet needs and the strategic importance of the universal…
Agus Heru Darjono, President Director at Metro Drug Indonesia, highlights the opportunities in the Indonesian Third Party Commercialization sector and emphasizes the importance of building the best team in order…
Holger Welters, President Director at Beiersdorf Indonesia, discusses the ambitious growth plan for emerging markets that is propelling the company to new heights and sheds light on the importance of…
Endang Hoyaranda, Commissioner and President Director at Prodia Group, elaborates on Prodia’s pioneering spirit when implementing its diversification business strategy and explains how the company has successfully completed its IPO…
Jorge Wagner, President Director at Boehringer Ingelheim Indonesia, explains the importance of innovation within the universal healthcare coverage program that is being implemented in Indonesia. He also illustrates how the…
Lin Neumann, Managing Director of AmCham Indonesia, highlights the opportunities in the Indonesian market, recent industry results, and the complex regulatory system in Indonesia: the main barrier to market access.…
See our Cookie Privacy Policy Here
